NCT07144228View on ClinicalTrials.gov

Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions

Prostate Cancer (Diagnosis)

Interventions

DEVICE

HeLP TM

lab test for prostate cancer

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

Hessian Labs Inc

UNKNOWN

lead

Duke University

OTHER

NCT07144228 - Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer | Biotech Hunter | Biotech Hunter